Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

AgomAb (Company)

Agonistic monoclonal antibody molecules

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
Also Known As
AgomAb Therapeutics
B2X
B2B
B2B
0
CEO
‌
Tim Knotnerus
0
Company Operating Status
Active
Country
Belgium
Belgium
Crunchbase URL
crunchbase.com/organiz...apeutics
CTO
‌
Torsten Dreier
0
Email Address
tim.knotnerus@agomab.com
Founded Date
2017
0
Headquarters
Ghent
Ghent
Industry
Liver disease
Liver disease
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Health technology
Health technology
Therapeutics
Therapeutics
Biotechnology
Biotechnology
Endocrine disease
Endocrine disease
Technology
Technology
Biology
Biology
Investors
Redmile Group
Redmile Group
Pontifax Venture Capital
Pontifax Venture Capital
Omnes Group
Omnes Group
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
V-Bio Ventures
V-Bio Ventures
Advent France Biotechnology
Advent France Biotechnology
BIVF
BIVF
Omnes Capital
Omnes Capital
Andera Partners
Andera Partners
Cormorant Asset Management
Cormorant Asset Management
Latest Funding Round Date
March 10, 2021
Latest Funding Round Amount (USD)
74,000,000
Latest Funding Type
Series B Round
Series B Round
LinkedIn URL
@company/agomab-therapeutics
Location
Belgium
Belgium
Number of Employees (Ranges)
11 – 50
0
Pitchbook URL
pitchbook.com/profiles...266527-81
Total Funding Amount (USD)
97,600,000
Twitter URL
@Agomab_
Official Website
agomab.com

Find more companies like AgomAb (Company)

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo